key: cord-0953540-0q24s5z2 authors: Nather, Katrin; Bolger, Fiachra; DiModica, Laurie; Fletcher‐Louis, Mary; Salvador, Javier; Pattou, François; Panton, Ulrik Haagen; Cancino, Ana‐Paula title: The impact of COVID‐19 on obesity services across Europe: A physician survey date: 2021-07-13 journal: Clin Obes DOI: 10.1111/cob.12474 sha: ef691e6dee36750162bf786b96a3e61ef88798cf doc_id: 953540 cord_uid: 0q24s5z2 Obesity is a risk factor for severe complications from coronavirus disease 2019 (COVID‐19). During the COVID‐19 pandemic in Spring 2020, many clinics and obesity centers across Europe were required to close. This study aimed to determine the impact of COVID‐19 on the provision of obesity services across 10 European countries via a survey of physicians (n = 102) specializing in treating persons with obesity (PwO). In total, 62–95 out of 102 physicians reported that COVID‐19 affected obesity‐related services, with cancellations/suspensions ranging from 50% to 100% across the 10 countries. Approximately 75% of cancellations/suspensions were provider‐ rather than patient‐initiated. A median increase of 20%–25% in waiting times was reported for most services across the countries. When services resume, 87 out of 100 physicians consider factors influencing down‐stream patient outcomes as the most relevant factors for prioritizing interventional treatment. Responses showed that 65 out of 102 and 36 out of 102 physicians believed it (highly) likely that a change in treatment guidance will occur to prioritize earlier interventional treatment for the management of PwO, by either using bariatric surgery or pharmacotherapy, respectively. Results from this study provide important learnings, such as opportunities for, and discrepancies in, the provision of alternative care in light of services cancellations or delays, which may be important for the future management of obesity, especially during future waves of COVID‐19 or other infectious pandemics. Obesity is a risk factor for severe complications from coronavirus disease 2019 . During the COVID-19 pandemic in Spring 2020, many clinics and obesity centers across Europe were required to close. This study aimed to determine the impact of COVID-19 on the provision of obesity services across 10 European countries via a survey of physicians (n = 102) specializing in treating persons with obesity (PwO). In total, 62-95 out of 102 physicians reported that COVID-19 affected obesity-related services, with cancellations/suspensions ranging from 50% to 100% across the 10 countries. Approximately 75% of cancellations/suspensions were provider-rather than patient-initiated. A median increase of 20%-25% in waiting times was reported for most services across the countries. When services resume, 87 out of 100 physicians consider factors influencing down-stream patient outcomes as the most relevant factors for prioritizing interventional treatment. Responses showed that 65 out of 102 and 36 out of 102 physicians believed it (highly) likely that a change in treatment guidance will occur to prioritize earlier interventional treatment for the management of PwO, by either using bariatric surgery or pharmacotherapy, respectively. Results from this study provide important learnings, such as opportunities for, and discrepancies in, the provision of alternative care in light of services cancellations or delays, which may be important for the future management of obesity, especially during future waves of COVID-19 or other infectious pandemics. Tracker provide indications that "stay at home" requirements were implemented in March 2020 and ranged from localized recommendations (e.g., Denmark, Finland, Sweden and the Netherlands) to localized and national lockdowns (Belgium, France, Ireland, Portugal, Spain and the UK) throughout the first wave of the COVID-19 pandemic. 1 The European Society of Residents in Urology reports major elective surgeries being cancelled in France, Germany, Italy, Spain and the UK as a result of the COVID-19 pandemic in Spring 2020, 2 a scenario that was likely mirrored across Europe. The cost of the disruption to medical services due to the pandemic has directly affected patients awaiting surgery. According to a study by the CovidSurg Collaborative, approximately 28.4 million elective surgeries were projected to be cancelled worldwide as a result of a 12-week period of peak disruption during the first wave of the COVID-19 pandemic. 3 In the UK, the decision to postpone all nonurgent elective operations for at least 3 months during the first wave of the pandemic (Spring 2020) was estimated to result in 516 000 surgeries being cancelled. 4 This backlog has since increased with subsequent lockdowns. 5 COVID-19 is associated with several comorbidities including obesity, arterial hypertension, chronic lung disease, diabetes and cancer, [6] [7] [8] with obesity being the most common comorbidity for patients infected with COVID-19. 9,10 Additionally, evidence suggests that persons with obesity (PwO) who contract COVID-19 have a higher risk of developing a severe illness due to the virus. 7, 8, [11] [12] [13] [14] [15] Several explanations for why PwO are more susceptible to severe disease with COVID-19 have been proposed, including impaired lung function, 16 endothelial dysfunction, 14 and inflammation. [17] [18] [19] Other respiratory diseases, including influenza 20,21 and the H1N1 2009 strain of influenza, 19, 22, 23 adversely affect PwO indicating that this population may be at heightened risk of developing severe illness due to COVID-19. Although younger age is considered to lower the risk for COVID-19 disease severity, a growing body of evidence indicates that obesity in people aged <60 years is a risk factor associated with increased COVID-19 disease severity and a risk factor for hospital admission and critical care. Patients with COVID-19 and a BMI between 30-34 kg/m 2 were 2.0 and 1.8 times more likely to be admitted to acute and critical care, respectively, compared with individuals with a BMI <30 kg/m 2 . 11 Additionally, those with a BMI ≥25 kg/m 2 had significantly higher odds of developing severe COVID-19 disease requiring supplemental oxygen and intensive care admission. 24 An inverse correlation between age and BMI has also been suggested, in which younger people admitted to hospital with COVID-19 were more likely to have obesity, indicating that in populations with a high prevalence of obesity, COVID-19 will affect younger populations more than initially reported. 25 Alongside obesity being linked to severe incidence of COVID-19, it has also been identified as an independent risk factor for high mortality in a large (>20 000 hospital inpatients) prospective observational cohort study in the UK between 6 February and 19 April 2020. 26 Given the link between obesity and severe COVID-19 disease and high mortality, it is imperative that PwO are adequately managed and treated. Any impact on the ability to adequately manage PwO may put patients at risk of developing and exacerbating comorbidities of obesity, and more severe infections of COVID-19. Current European guidelines for the treatment of obesity recommend an integrated treatment of obesity that may include diet, physical activity, pharmacological treatment, behavioural therapy and if indicated, bariatric or metabolic surgery, with multidisciplinary provision of care. 27, 28 A recent publication by Rubino et al., provides comprehensive recommendations for prioritizing and managing surgical candidates and post-operative patients during and after the peak of COVID-19 waves, including pre-operative screening, non-surgical interventions and triaging of patients for priority surgery. 29 When surgeries can resume, it has been proposed to stratify PwO based on a benefit/risk assessment with priority for those PwO whose need for surgery is high provided that the risk of morbidity due to the surgery is very low. 30 Increased vigilance, priority on COVID-19 detection and testing, and aggressive therapy are recommendations for PwO and COVID-19 infections. 23 Given the highly relevant link between COVID-19 and obesity for healthcare services and public health bodies, it is essential to understand how services for PwO have been impacted by the pandemic. Here, we report the results of a quantitative survey with physicians involved in the treatment of PwO to understand the impact of COVID-19 on obesity services across Europe in Spring 2020. Table S1 ). In (Table S2) . Across all countries, the COVID-19 pandemic impacted all obesity services considered, with routine medical consultations by specialists and non-specialists, and bariatric procedures reported as affected by the greatest number of physicians per country, whilst other health-related consultations by a multi-disciplinary team were reported to be affected by COVID-19 by the least number of physicians per country. Physicians were asked to provide the percentage of obesity appointments cancelled or suspended by the provider or patient due to the COVID-19 pandemic. For all physicians, the percentage of cancellations or suspensions (hereafter referred to as cancellations) was 87% for local/community weight management services, 86% for bariatric procedures, 84% for consultations at speciality obesity centers, 80% for other health-related consultations led by a multidisciplinary team, and 79% for medical consultations. The cancellations were mainly driven by the provider (57%-71%) and fewer cancellations were due to the patient (15%-23%). Individual country-level data are provided in Table 1 (Table S3) and Table 2 country is provided in Figure 3 and Table S4-Table S6 . (10) 81 (10) 81 (10) 99 (9) 59 (10) 83 (10) 61 (10) 98 (5) 75 (10) 87 (11) 79 ( (7) 86 (9) 98 (5) 81 (4) 85 (10) 80 (6) 96 (9) 69 (5) 90 (9) 87 ( Other health-related consultations led by a multidisciplinary team Total, % (n) 88 (2) 75 (3) 84 (8) 100 (5) 58 (7) 83 (9) 67 (10) 96 (8) 70 (2) 84 (8) 80 ( (10) 85 (10) 82 (10) 97 (6) 69 (10) 84 (9) 80 (9) 98 (6) 79 (10) 89 (7) 84 (87) Provider (10) 86 (9) 82 (10) 100 (6) 57 (7) 86 (10) 94 (9) 97 (7) 79 (9) 89 (7) 86 (84) Provider, % 32 For example, limited screening, referral and diagnosis for cancer services during the pandemic could lead to a 20% increase in cancer deaths in the next 12 months. 33, 34 Obesity is a chronic, progressive and relapsing disease that requires long-term treatment. 35 Increased BMI is a major risk factor for disease-related complications and comorbidities. 36 Failure to treat or poor management of PwO leads to an increased risk of short-term and longterm complications and death. 37 Although a high proportion of physicians specified that alternative management was provided to PwO whose services had been cancelled, a substantial number of Although physicians highlight that prioritization of bariatric surgery as an interventional approach in PwO post-COVID-19 is highly likely, benefit and risk to the patient will need to be considered. Consequently, these procedures may be at risk of cancellation dur- A global panel database of pandemic policies (Oxford COVID-19 government response tracker) The impact of COVID-19 on European health care and urology trainees Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans COVID-19 disruption will lead to 28 million surgeries cancelled worldwide Growing backlog of planned surgery due to covid-19 Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang High prevalence of obesity in severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation SARS-CoV-2 in Spanish intensive care units: early experience with 15-day survival in Vitoria Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in new York City: prospective cohort study Increased severity of COVID-19 in people with obesity: are we overlooking plausible biological mechanisms? Coronavirus (COVID-19) & Obesity Obesity: systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function SARS-CoV-2 infection and obesity: common inflammatory and metabolic aspects Interaction of obesity and infections Impact of obesity on influenza a virus pathogenesis, immune response, and evolution Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses. Influenza Other Respi Viruses Factors associated with death or hospitalization due to pandemic 2009 influenza a(H1N1) infection in California Obesity and its implications for COVID-19 mortality Association of higher body mass index with severe coronavirus disease 2019 (COVID-19) in younger patients Obesity could shift severe COVID-19 disease to younger ages Features of 20 133 UKpatients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study European guidelines for obesity management in adults Obesity: identification, assessment and management Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery SOFFCO-MM guidelines for the resumption of bariatric and metabolic surgery during and after the Covid-19 pandemic International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). The IFSO Global Registry IFSO Global Registry Excess deaths from COVID-19 and other causes Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study Obesity: a chronic relapsing progressive disease process. A position statement of the world obesity federation Obesity and overweight Fact Sheet Morbidity and mortality associated with obesity The economic burden of obesity in Germany: results from the population-based KORA studies Antibody status and incidence of SARS-CoV-2 infection in health care workers New obesity strategy unveiled as country urged to lose weight to beat coronavirus (COVID-19) and protect the NHS Prise en charge des personnes en situation d'obesite dans le cadre de la gestion de l'epidemie de COVID-19 European Association for the Study of Obesity (EASO) Obesity and COVID-19: the two sides of the coin Supporting weight management services during the COVID-19 pandemic The impact of COVID-19 on obesity services across Europe: A physician survey